Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

ยฉ 2026 Go Backs. All rights reserved.

Medium RiskFDA Drug
Medications & Supplements/Prescription Drugs

Ibuprofen and Famotidine Tablets Recalled for Foreign Tablet Presence

Agency Publication Date: January 17, 2024
Share:
Sign in to monitor this recall

Summary

Ascend Laboratories, LLC is recalling 3,288 bottles of Ibuprofen and Famotidine Tablets 800mg/26.6mg because a stray tablet of a different medication, Rasagiline Mesylate (1 mg), was found inside an unopened bottle. The tablets are prescription-only and are used to treat pain and inflammation while protecting the stomach. No injuries or incidents have been reported to date regarding this error.

Risk

Taking an unintended medication like Rasagiline Mesylate can lead to serious drug interactions or adverse side effects, especially if the user is already taking other medications. Rasagiline is a medication used for Parkinson's disease and must be taken under strict medical supervision.

What You Should Do

  1. This recall affects Ibuprofen and Famotidine Tablets 800mg/26.6mg (90-count bottles) with NDC 67877-626-90, lot number 23140190, and an expiration date of December 31, 2024.
  2. Check the bottle label for the NDC code and the printed lot number to see if your medication is part of this recall.
  3. If you have health concerns, contact your healthcare provider or pharmacist. Return any unused product to the place of purchase for a refund, throw it away, or contact Ascend Laboratories, LLC for further instructions.
  4. Call the FDA Consumer Complaint hotline at 1-888-723-3332 for additional questions.

Your Remedy Options

You have 2 options:

๐Ÿ’ฐOption 1: Full Refund
How to: Contact your healthcare provider or pharmacist for guidance, or return any unused product to the place of purchase for a refund
๐Ÿ—‘๏ธOption 2: Dispose of Product
How to: Throw the product away. For prescription medications, a DEA take-back location or pharmacy mail-back program is preferred when available.

Affected Products

Product: Ibuprofen and Famotidine Tablets 800mg/26.6mg (90 Tablets per Bottle)
Variants: 800mg/26.6mg, 90 Tablets, Rx Only
Lot Numbers:
23140190 (Exp. Date 12/31/2024)
NDC:
67877-626-90

Manufactured by Alkem Laboratories Ltd., India; Distributed by Ascend Laboratories, LLC.

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 93701
Status: Active
Manufacturer: Ascend Laboratories, LLC
Sold By: pharmacies
Manufactured In: India, United States
Units Affected: 3,288 bottles
Distributed To: Nationwide

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES ยท Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.